How do you approach rescue therapy for your patients with asthma? Explore data on new treatment options with Timothy Hudd, PharmD, RPh, AE-C, in our Business Booster session on Oct. 8.
Hudd, a professor at MCPHS University in Boston, will share insights on the role variable inflammation plays in the occurrence of asthma exacerbations and the consequent burden of systemic corticosteroid exposures. He’ll also share recent recommendations from the Global Initiative for Asthma and the National Asthma Education and Prevention Program and data on an inhaled corticosteroid-containing treatment that could help you expand your perspective on rescue therapies.
Learn more and register here. This session is sponsored by AstraZeneca.
NCPA
